PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2103
https://www.valueinhealthjournal.com/article/S1098-3015(12)03817-X/fulltext
Title :
PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03817-X&doi=10.1016/j.jval.2012.08.2103
First page :
A420
Section Title :
Cancer
Open access? :
No
Section Order :
757